StreetInsider.com News Articles

Form 8-K OSR Health, Inc. For: Aug 27

Fri, 28 Aug 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260828/26993196.html

Form 8-K OSR Health, Inc. For: Aug 27

Fri, 28 Aug 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260828/26993196.html

Form 8-K OSR Health, Inc. For: Aug 27

Fri, 28 Aug 2026 08:00:00 -0400

si-local-file:///var/storage/secattach/20260828/26993196.html

Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc.

Thu, 27 Aug 2026 17:00:00 -0400

NEW YORK CITY, NY / ACCESS Newswire / August 27, 2026 / Emerging Growth Research, LLC ("Emerging Growth Research" or "EGR") today announced the release of its company-sponsored research flash report on OSR Health, Inc. (NASDAQ:OSRH), a global healthcare holding company advancing oral immunotherapies for cancer and age-related disease, non-invasive glucose monitoring technology, and fourth-party logistics (4PL) operations.

This release is being issued as an updated version of EGR's previously published press release. The updated release is intended to clarify the company-sponsored nature of the research and provide additional disclosure regarding EGR's financial

Emerging Growth Research Issues Company-Sponsored Research Flash Report on OSR Health, Inc.

Thu, 27 Aug 2026 17:00:00 -0400

Form 8-K OSR Health, Inc. For: Aug 25

Tue, 25 Aug 2026 11:28:00 -0400

si-local-file:///var/storage/secattach/20260825/26973012.html

Form 8-K OSR Health, Inc. For: Aug 25

Tue, 25 Aug 2026 11:28:00 -0400

si-local-file:///var/storage/secattach/20260825/26973012.html

OSR Health faces Nasdaq delisting, plans appeal and $15M put option

Fri, 21 Aug 2026 11:47:29 -0400

OSR Health, Inc. (NASDAQ: OSRH) received a Nasdaq Staff Delisting Determination on August 19, 2026, and plans to submit a formal hearing request to the Nasdaq Independent Hearings Panel no later than August 26, according to a shareholder letter from CEO Peter Hwang.

The company said it will present a compliance plan and evidence to support its continued listing, including trading activity from August 17 and 18, which it described as "extraordinary." A trading suspension is expected on August 26.

OSR Health also highlighted a $15 million Put Option it holds against BCM Europe AG, a Swiss life sciences investment firm backed

OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission

Fri, 21 Aug 2026 11:45:00 -0400

The Company details its Nasdaq hearing request, its $15 million Put Option, and continued development across its subsidiary pipeline

BELLEVUE, WA / ACCESS Newswire / August 21, 2026 / OSR Health, Inc. (NASDAQ:OSRH) today released the following letter from its Chief Executive Officer to shareholders.

To OSR Health Shareholders:

I am aware that many of you are watching closely to see what comes next. I want to address some of your concerns directly and with specificity.

OSR Health's stock is showing resilience this morning after a difficult session yesterday. In our opinion, that resilience

OSR Health: Preparing Our Appeal, Advancing Our Catalysts, Continuing Our Mission

Fri, 21 Aug 2026 11:45:00 -0400

The Company details its Nasdaq hearing request, its $15 million Put Option, and continued development across its subsidiary pipeline

BELLEVUE, WA / ACCESS Newswire / August 21, 2026 / OSR Health, Inc. (NASDAQ:OSRH) today released the following letter from its Chief Executive Officer to shareholders.

To OSR Health Shareholders:

I am aware that many of you are watching closely to see what comes next. I want to address some of your concerns directly and with specificity.

OSR Health's stock is showing resilience this morning after a difficult session yesterday. In our opinion, that resilience

Form 8-K OSR Health, Inc. For: Aug 19

Wed, 19 Aug 2026 17:06:00 -0400

si-local-file:///var/storage/secattach/20260819/26951020.html

Form 8-K OSR Health, Inc. For: Aug 19

Wed, 19 Aug 2026 17:06:00 -0400

si-local-file:///var/storage/secattach/20260819/26951020.html

OSR Health faces Nasdaq delisting, stock suspension set for Aug. 26

Wed, 19 Aug 2026 15:45:53 -0400

OSR Health, Inc. (NASDAQ: OSRH) announced it has received a Staff Delisting Determination from the Nasdaq Listing Qualifications Department, citing the company's failure to meet the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).

The company's common stock and warrants will be suspended from trading on The Nasdaq Capital Market at the opening of business on August 26, 2026. Because OSR Health utilized a second 180-day compliance period under Nasdaq rules, a hearing request will not automatically stay the trading suspension.

OSR Health intends to appeal the determination by requesting a hearing before the Nasdaq Independent Hearings Panel under the Nasdaq

OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal

Wed, 19 Aug 2026 15:45:00 -0400

BELLEVUE, WA / ACCESS Newswire / August 19, 2026 / OSR Health, Inc. (NASDAQ:OSRH) ("OSR Health" or the "Company") today announced that it has received a written Staff Delisting Determination (the "Determination") from the Nasdaq Listing Qualifications Department notifying the Company that its common stock and warrants are subject to delisting from The Nasdaq Capital Market as a result of the Company's failure to regain compliance with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2).

Nasdaq Hearing Request

The Company intends to request a hearing before the Nasdaq Independent Hearings Panel (the

OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal

Wed, 19 Aug 2026 15:45:00 -0400

Nasdaq Hearing Request

The Company intends to request a hearing before the Nasdaq Independent Hearings Panel (the

OSR Health faces Nasdaq delisting risk after missing $1 bid threshold

Wed, 19 Aug 2026 06:32:58 -0400

OSR Health, Inc. (NASDAQ: OSRH) disclosed in a shareholder letter dated August 19, 2026, that the company has not yet received an official communication from Nasdaq regarding its compliance status, as the stock price fell short of the exchange's $1.00 minimum bid requirement.

The company's shares reached an intraday high of $0.84 on August 18, sixteen cents below the Nasdaq minimum bid threshold, before declining in the final 90 minutes of trading. OSR Health said it is examining trading data and intends to share findings with shareholders and relevant authorities.

Trading volume on August 17 reached approximately 370 million shares, with the

OSR Health Sees Global Shareholder Momentum at Critical Inflection Point

Wed, 19 Aug 2026 06:30:00 -0400

Company cites extraordinary trading activity, global shareholder support, and continued commitment to Nasdaq compliance and the CVR program.

BELLEVUE, WA / ACCESS Newswire / August 19, 2026 / OSR Health, Inc. (NASDAQ:OSRH) today released the following letter from its Chief Executive Officer to shareholders.

To Every OSR Health Shareholder, Wherever You Are:

OSR Health is at an inflection point, one that I believe will be looked back upon as the moment this company's underlying value began to be recognized by the broader market. Before that recognition fully arrives, I want to speak directly to

OSR Health Sees Global Shareholder Momentum at Critical Inflection Point

Wed, 19 Aug 2026 06:30:00 -0400

Company cites extraordinary trading activity, global shareholder support, and continued commitment to Nasdaq compliance and the CVR program.

BELLEVUE, WA / ACCESS Newswire / August 19, 2026 / OSR Health, Inc. (NASDAQ:OSRH) today released the following letter from its Chief Executive Officer to shareholders.

To Every OSR Health Shareholder, Wherever You Are:

Form SCHEDULE 13G/A OSR Health, Inc. Filed by: joint protein central inc.

Mon, 17 Aug 2026 17:55:00 -0400

si-local-file:///var/storage/secattach/20260817/26939093.html

Form SCHEDULE 13G/A OSR Health, Inc. Filed by: joint protein central inc.

Mon, 17 Aug 2026 17:55:00 -0400

si-local-file:///var/storage/secattach/20260817/26939093.html

Form 10-Q OSR Health, Inc. For: Jun 30

Fri, 14 Aug 2026 15:08:00 -0400

si-local-file:///var/storage/secattach/20260814/26929364.html

Form 10-Q OSR Health, Inc. For: Jun 30

Fri, 14 Aug 2026 15:08:00 -0400

si-local-file:///var/storage/secattach/20260814/26929364.html

OSR Health faces Nasdaq deadline amid out-licensing talks

Tue, 11 Aug 2026 08:54:25 -0400

OSR Health, Inc. (NASDAQ: OSRH) disclosed that two of its subsidiaries have received inbound inquiries regarding potential out-licensing opportunities, as the company approaches a Nasdaq compliance deadline regarding its stock price.

In a letter to shareholders, CEO Peter Hwang stated that one subsidiary is at the preliminary term sheet negotiation phase, while a second is at an early stage. No parties or technologies were identified.

The company faces an August 18 deadline by which Nasdaq is expected to communicate its determination on OSRH's continued listing if the stock has not regained the minimum bid price requirement of $1.00 per share.

Hwang addressed shareholder

OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development

Tue, 11 Aug 2026 08:52:00 -0400

Founder and CEO addresses the Company's Nasdaq listing status and accelerating subsidiary business development

BELLEVUE, WA / ACCESS Newswire / August 11, 2026 / OSR Health, Inc. (NASDAQ:OSRH) today released the following letter from its Chief Executive Officer to shareholders.

Dear Shareholders,

Today marks five business days before August 18, the practical deadline by which the Nasdaq is expected to communicate its determination regarding OSRH's continued listing if our stock price has not regained the minimum bid price requirement of $1.00 per share as of the market close.

As CEO of OSRH, I want to

OSR Health CEO Reaffirms Confidence and Highlights Subsidiary Business Development

Tue, 11 Aug 2026 08:52:00 -0400

Founder and CEO addresses the Company's Nasdaq listing status and accelerating subsidiary business development

BELLEVUE, WA / ACCESS Newswire / August 11, 2026 / OSR Health, Inc. (NASDAQ:OSRH) today released the following letter from its Chief Executive Officer to shareholders.

Dear Shareholders,

As CEO of OSRH, I want to